Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral develops devices for unmet medical needs. Sepsis occurs in 1.7M Americans/year causing 250K deaths, often caused by endotoxin. Our devices measure and remove endotoxin from the bloodstream. An FDA confirmatory trial is underway. Dialco, a Spectral sub, offers SAMI, a novel instrument for renal replacement, cleared by FDA. Dialco is seeking FDA approval for DIMI a unique home dialysis enabler. These devices have large commercial potential


TSX:EDT - Post by User

Comment by BayStreetWildon Oct 27, 2022 12:31pm
132 Views
Post# 35053468

RE:RE:Tic... toc... tic... toc? Nope,

RE:RE:Tic... toc... tic... toc? Nope,

Yeah, im thrilled too. Sitting in 90% cash right now and waiting for tax loss season to kick in. I too bought in the 20s and am looking forward to doing so again. Will throw some stink bids in the 10's for sure. 

mercedesman wrote: Stuck-upatree

Despite your attempts to paint this equity is nothing but "disappointment", I am overall satisfied.  However I am reserving judgement on the ONLY thing that brings me disappointment - and that is the pace of enrolment - over the past 12 -18 months.

Reasons I am "overall" satisfied:

  • slow pace does not equate with ultimate failure, just delayed success (and Yes more dilution in the meantime which may water down a fraction of the ultimate gain/upside)
  • the anticipated fall flu season has just started (the period that JK expects to see an increase in enrolment, based on higher incidences of Sepsis in the US)  Let's see if they come through by Dec/Jan.   Noting that ICU's will START seeing flu patients over the next month or so.  Will I be satsified if Tigris is at 50 or 60 by Dec 31?  Absolutely not!
  • I am up  almost 100% on my last significant purchses of Spectral last Nov/Dec (much more on my trading position)  Whereas the general markets are down 25-30% during the same time period, by comparison.  Hardly disappointing - unless of course you failed to participate by averaging down on yur Spectral holdings, or you were precient enough to have shorted the market instead.  Even then it would have been hard pressed to duplicate the return of Spectral over the past 10 months.
  • Why else am I overall "satisfied"?  Simply stated, 2022 PR's, I would argue, paint a picture of increased odds of success (e.g BTD designation, Strategic partner equity participation, more RWE, etc.).  Again, the slow enrolment coupled with new developments in 2022 point to delayed success vs. out and out failure, despite what you want us to believe.
Despite your claim that Spectral shareholders will never profit, I vehemently disagree. Firstly, nimble investors that are paying attention already have, with much more upside to come.  Secondly even frozen cats stuck-upatree, like yourself, can be rescued with a little patience...but you seem to prefer to climb higher to even more precarious branches...all the while whining/crying to others.




MM


<< Previous
Bullboard Posts
Next >>